At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 16, 2026 at 16:31 ET
Four corporate insiders at United Therapeutics, including the CEO, CFO, and General Counsel, sold shares in open-market transactions over a 5-day period, realizing $1.34 million in total proceeds. These sales were part of broader option exercise and tax-related transactions, with multiple executives exercising in-the-money options and selling a portion of the resulting shares.
- CEO Martine Rothblatt sold $702,522 worth of shares over two days (248 shares on 4/17, 977 on 4/20) at prices between $572.41 and $575.38
- CFO James Edgemon sold $802,084 in shares (520 on 4/16, 880 on 4/20) following the exercise of 20,000 options
- EVP Paul Mahon sold $114,807 after exercising 8,300 options
- Director Christopher Patusky sold $578,880 following the exercise of 1,000 options
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access